CD8A and Patent ductus arteriosus: We have also shown that in PDA mouse models, targeting of PI3Kγ led to improved survival and responsiveness to standard-of-care chemotherapy, by reprogramming tumor-associated macrophages to stimulate CD8+ T cell–mediated tumor suppression and inhibiting tumor cell invasion, metastasis and desmoplasia [14].